Aijun Liao Selected Research

Aijun Liao Research Topics

Disease

11	Neoplasms (Cancer) 12/2023 - 01/2017
7	Multiple Myeloma 03/2024 - 01/2017
5	Leukemia 08/2014 - 11/2010
3	Stomach Neoplasms (Stomach Cancer) 12/2023 - 02/2016
3	Neoplasm Metastasis (Metastasis) 12/2023 - 10/2017
2	Amyloidosis 08/2021 - 01/2021
2	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 04/2012
1	Esophagitis 01/2024
1	Gastroesophageal Reflux (GERD) 01/2024
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2023
1	Disease Progression 01/2023
1	Schizophrenia (Dementia Praecox) 01/2022
1	Heart Failure 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Male Infertility (Male Sterility) 01/2022
1	Immune System Diseases (Immune Disorders) 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Dyspnea (Shortness of Breath) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Immunoglobulin Light-chain Amyloidosis 01/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2020
1	Hemorrhage 02/2019
1	Hepatocellular Carcinoma (Hepatoma) 02/2019
1	Carcinogenesis 08/2018
1	Adenocarcinoma of Lung 10/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2017
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Pancytopenia 01/2013
1	Thrombocytosis (Thrombocythemia) 01/2013
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2013
1	Large Granular Lymphocytic Leukemia 11/2010

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2018
3	Bortezomib (Velcade)FDA Link 01/2023 - 02/2012
3	Long Noncoding RNAIBA 01/2022 - 10/2017
3	Fingolimod Hydrochloride (FTY720)FDA Link 11/2020 - 09/2011
2	Proteasome InhibitorsIBA 03/2024 - 02/2012
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2017 - 02/2012
1	Circular DNAIBA 03/2024
1	fexuprazanIBA 01/2024
1	Esomeprazole (Nexium)FDA Link 01/2024
1	NLR ProteinsIBA 12/2023
1	InflammasomesIBA 12/2023
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	RNA Splicing FactorsIBA 01/2023
1	Lenalidomide (CC 5013)FDA Link 01/2023
1	Volatile Fatty AcidsIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 08/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	shengjingIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2020
1	Protein Isoforms (Isoforms)IBA 05/2020
1	LithiumIBA 01/2020
1	Escitalopram FDA Link 01/2020
1	Piwi-Interacting RNAIBA 01/2020
1	Vitamin K Epoxide ReductasesIBA 02/2019
1	MTOR InhibitorsIBA 02/2019
1	Blood Coagulation Factors (Coagulation Factor)IBA 02/2019
1	Prothrombin (Factor II)IBA 02/2019
1	Complement C1q (C1q Complement)IBA 01/2019
1	Competitive Endogenous RNAIBA 08/2018
1	Phosphotransferases (Kinase)IBA 10/2017
1	Cadherins (E-Cadherin)IBA 01/2017
1	Actin Depolymerizing Factors (Cofilins)IBA 01/2017
1	VimentinIBA 01/2017
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2017
1	Destrin (Actin Depolymerizing Factor)IBA 01/2017
1	diallyl disulfide (diallyl disulphide)IBA 01/2017
1	Lim KinasesIBA 01/2017
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 02/2016
1	Small Interfering RNA (siRNA)IBA 08/2014
1	Daunorubicin (Cerubidine)FDA LinkGeneric 08/2014
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2013
1	NF-kappa B (NF-kB)IBA 02/2012
1	SurvivinIBA 11/2010
1	Proteins (Proteins, Gene)FDA Link 11/2010
1	CeramidesIBA 11/2010

Therapy/Procedure

4	Therapeutics 01/2021 - 02/2012
2	Drug Therapy (Chemotherapy) 01/2017 - 01/2013
1	Immunotherapy 12/2023
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021
1	Immunomodulation 01/2019